Literature DB >> 16838230

New drugs for Clostridium difficile infection.

John G Bartlett.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16838230     DOI： 10.1086/506387

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  8 in total

1.  Prospective observational study comparing three different treatment regimes in patients with Clostridium difficile infection.

Authors:  Judith M Wenisch; Daniela Schmid; Hung-Wei Kuo; Franz Allerberger; Verena Michl; Philip Tesik; Gerhard Tucek; Hermann Laferl; Christoph Wenisch
Journal:  Antimicrob Agents Chemother       Date:  2012-01-17       Impact factor: 5.191

Review 2.  Future novel therapeutic agents for Clostridium difficile infection.

Authors:  Hoonmo L Koo; Kevin W Garey; Herbert L Dupont
Journal:  Expert Opin Investig Drugs       Date:  2010-07       Impact factor: 6.206

3.  MBX-500, a hybrid antibiotic with in vitro and in vivo efficacy against toxigenic Clostridium difficile.

Authors:  Michelle M Butler; Dean L Shinabarger; Diane M Citron; Ciarán P Kelly; Sofya Dvoskin; George E Wright; Hanping Feng; Saul Tzipori; Terry L Bowlin
Journal:  Antimicrob Agents Chemother       Date:  2012-06-25       Impact factor: 5.191

4.  Current Treatment Options for Severe Clostridium difficile-associated Disease.

Authors:  Edie P Shen; Christina M Surawicz
Journal:  Gastroenterol Hepatol (N Y)       Date:  2008-02

Review 5.  Clostridium difficile-associated disease: changing epidemiology and implications for management.

Authors:  Robert C Owens
Journal:  Drugs       Date:  2007       Impact factor: 9.546

6.  Lack of Association Between the Clinical Outcome of Clostridium difficile Infection and Current Steroids Use.

Authors:  Ahmed Dirweesh; Chikezie Alvarez; Muhammad Khan; Bushra Ambreen; Rishitha Yelisetti; Shaikh Fawwad Hamiz; Sana Zia; Muhammad Tahir; Vincent A DeBari; Donald Christmas; Sara Wallach
Journal:  Gastroenterology Res       Date:  2017-04-19

7.  Clostridium difficile: the increasingly difficult pathogen.

Authors:  Aurora Pop-Vicas; Marguerite A Neill
Journal:  Crit Care       Date:  2008-02-07       Impact factor: 9.097

8.  Recommendations for the diagnosis and treatment of Clostridioides difficile infection: An official clinical practice guideline of the Spanish Society of Chemotherapy (SEQ), Spanish Society of Internal Medicine (SEMI) and the working group of Postoperative Infection of the Spanish Society of Anesthesia and Reanimation (SEDAR).

Authors:  E Bouza; J M Aguado; L Alcalá; B Almirante; P Alonso-Fernández; M Borges; J Cobo; J Guardiola; J P Horcajada; E Maseda; J Mensa; N Merchante; P Muñoz; J L Pérez Sáenz; M Pujol; E Reigadas; M Salavert; J Barberán
Journal:  Rev Esp Quimioter       Date:  2020-02-20       Impact factor: 1.553
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.